Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 23;219(6):877-883.
doi: 10.1093/infdis/jiy602.

HIV-Associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 Counts

Affiliations

HIV-Associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 Counts

Lillian Tugume et al. J Infect Dis. .

Abstract

Background: Cryptococcal meningitis can occur in persons with less-apparent immunosuppression. We evaluated clinical characteristics and outcomes of persons with HIV-related Cryptococcus presenting with higher CD4 counts.

Methods: We enrolled 736 participants from 2 prospective cohorts in Uganda and South Africa from November 2010 to May 2017. We compared participants with CD4 <50, 50-99, or ≥100 cells/μL by clinical characteristics, cerebrospinal fluid (CSF) parameters, and 18-week survival.

Results: Among first episode of cryptococcosis, 9% presented with CD4 ≥100 cells/μL. Participants with CD4 ≥100 cells/μL presented more often with altered mental status (52% vs 39%; P = .03) despite a 10-fold lower initial median CSF fungal burden of 7850 (interquartile range [IQR] 860-65500) versus 79000 (IQR 7400-380000) colony forming units/mL (P < .001). Participants with CD4 ≥100 cells/μL had higher median CSF levels of interferon-gamma, interleukin (IL)-6, IL-8, and IL-13, and lower monocyte chemokine, CCL2 (P < .01 for each). Death within 18 weeks occurred in 47% with CD4 <50, 35% with CD4 50-99, and 40% with CD4 ≥100 cells/μL (P = .04).

Conclusion: HIV-infected individuals developing cryptococcal meningitis with CD4 ≥100 cells/μL presented more frequently with altered mental status despite having 10-fold lower fungal burden and with greater Th2 (IL-13) immune response. Higher CD4 count was protective despite an increased propensity for immune-mediated damage, consistent with damage-response framework.

Clinical trial registration: NCT01075152 and NCT01802385.

Keywords: AIDS; CD4 T cells; CSF biomarkers; HIV; cryptococcal meningitis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Proportions of deaths (95% confidence interval) by 18 weeks for 4 CD4 groups (CD4 ≤25, 25–50, 51–99, and ≥100 cells/μL).
Figure 2.
Figure 2.
Kaplan-Meier curve for cryptococcal meningitis survival by baseline CD4 group.

References

    1. Rajasingham R, Smith RM, Park BJ, et al. . Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis 2017; 17:873–81. - PMC - PubMed
    1. Stenzel W, Müller U, Köhler G, et al. . IL-4/IL-13-dependent alternative activation of macrophages but not microglial cells is associated with uncontrolled cerebral cryptococcosis. Am J Pathol 2009; 174:486–96. - PMC - PubMed
    1. Müller U, Stenzel W, Köhler G, et al. . IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J Immunol 2007; 179:5367–77. - PubMed
    1. Jarvis JN, Meintjes G, Bicanic T, et al. . Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis. PLoS Pathog 2015; 11:e1004754. - PMC - PubMed
    1. Scriven JE, Graham LM, Schutz C, et al. . The CSF immune response in HIV-1-associated cryptococcal meningitis: macrophage activation, correlates of disease severity, and effect of antiretroviral therapy. J Acquir Immune Defic Syndr 2017; 75:299–307. - PMC - PubMed

Publication types

MeSH terms

Associated data